Here are 5 interesting findings from the October 2019 issue of AJMC®.
Hi, I’m Christina Mattina for The American Journal of Managed Care®. Here are 5 findings from research published in the October issue.
Variation in US Private Health Plans’ Coverage of Orphan Drugs
1. Health plans are less likely to restrict coverage of orphan drugs than nonorphan drugs, but the frequency of orphan drug restrictions varied widely across plans, from 11% to 65%. Orphan drugs that had higher annual costs and were indicated for diseases with a higher prevalence were more likely to have coverage restrictions.
Ease of Ordering High- and Low-Value Services in Various Electronic Health Records
2. A survey found no association between the clinical value of a service and how easy it is for a physician to order it in the electronic health record, suggesting that a redesign of these systems may change the workflow to facilitate the use of more high-value care and less low-value care.
Can Accountable Care Divert the Sources of Hospitalization?
3. Oregon’s Medicaid accountable care delivery model was linked to reductions in hospital admissions, especially preventable admissions, among women of reproductive age. The coordinated care organizations created by the model offer incentives to emphasize primary care and encourage quality improvement.
Physician Clinical Knowledge, Practice Infrastructure, and Quality of Care
4. The level of infrastructure within a physician practice is related to care quality outcomes, but that association is moderated by physicians’ score on the Maintenance of Certification exam, suggesting that physician skill and knowledge is important for translating infrastructure into better patient outcomes.
Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis
5. For patients with early, rapidly progressive rheumatoid arthritis, treatment with first-line abatacept, compared with a first-line tumor necrosis factor inhibitor, was associated with lower healthcare resource use in the first 6 months of treatment and higher odds of achieving low disease activity within 100 days of treatment initiation.
To read all of these studies and more, visit AJMC.com.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen